[Ala107]MBP (104-118)

[Ala107]MBP (104-118) is an noncompetitive peptide inhibitors of protein kinase C (PKC), with IC50s ranging from 46-145 μM[1].

Product Specifications

CAS Number

[99026-77-4]

UNSPSC

12352209

Target

PKC

Type

Peptides

Related Pathways

Epigenetics; TGF-beta/Smad

Applications

Cancer-Kinase/protease

Field of Research

Others

Assay Protocol

https://www.medchemexpress.com/ala107-mbp-104-118.html

Solubility

H2O

Smiles

O=C(N[C@@H](CCCCN)C(NCC(N[C@@H](C)C(NCC(N[C@@H](CC(C)C)C(N[C@@H](CO)C(N[C@@H](CC(C)C)C(N[C@@H](CO)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC1=CC=CC=C1)C(N[C@@H](CO)C(N[C@@H](CC2=CNC3=CC=CC=C23)C(NCC(N[C@@H](C)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CN

Molecular Formula

C67H104N20O19

Molecular Weight

1493.67

References & Citations

[1]Su HD, et, al. Synthetic myelin basic protein peptide analogs are specific inhibitors of phospholipid/calcium-dependent protein kinase (protein kinase C) . Biochem Biophys Res Commun. 1986 Jan 14; 134 (1) : 78-84.